Ausdal Financial Partners’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $628K | Buy |
+9,100
| New | +$628K | 0.04% | 368 |
|
|
2024
Q4 | – | Sell |
-3,841
| Closed | -$457K | – | 582 |
|
|
2024
Q3 | $457K | Buy |
3,841
+200
| +5% | +$23.8K | 0.05% | 330 |
|
|
2024
Q2 | $520K | Buy |
3,641
+230
| +7% | +$32.8K | 0.06% | 284 |
|
|
2024
Q1 | $438K | Buy |
3,411
+292
| +9% | +$37.5K | 0.05% | 294 |
|
|
2023
Q4 | $323K | Sell |
3,119
-240
| -7% | -$24.8K | 0.04% | 335 |
|
|
2023
Q3 | $305K | Buy |
+3,359
| New | +$305K | 0.04% | 334 |
|
|
2016
Q1 | – | Sell |
-8
| Closed | – | – | 759 |
|
|
2015
Q4 | $0 | Buy |
+8
| New | – | ﹤0.01% | 1320 |
|